ProShares Ultra Health Care RXL
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.95%
- Net assets
- $72.1M
- Holdings
- 70
- 12-month distribution yield
- 0.95%
- Asset class
- Derivatives-based
ProShares Ultra Health Care (RXL) is an exchange-traded fund listed on NYSE Arca in the United States, issued by ProShares. Its category is Derivatives-based. Its last price was US$66.31 on 20 Oct 2026. Its net expense ratio is 0.95% a year, from its prospectus dated 7 Apr 2025. It reported net assets of US$72.08 million as of 31 May 2026. Its latest holdings report lists 70 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.63 a unit, a 12-month distribution yield of 0.95%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 1.05%
- Net, after fee waivers or reimbursements
- 0.95%
- Management fee
- 0.75%
- Prospectus date
- 7 Apr 2025
- Filed with the SEC
- 7 Apr 2025
Size and reporting
- Net assets
- $72,080,935
- Total assets
- $79,486,672
- Holdings as of
- 31 May 2026
- Report made public
- 28 Jul 2026 (58 days after the month end)
Top holdings
Largest 25 of 70 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | US5324571083 | 12.67% | $9.1M | Equity (common) | United States | USD |
| 2 | ProShares GENIUS Money Market ETF | US74350P6916 | 11.81% | $8.5M | Other | United States | USD |
| 3 | Johnson & Johnson | US4781601046 | 7.86% | $5.7M | Equity (common) | United States | USD |
| 4 | AbbVie, Inc. | US00287Y1091 | 5.57% | $4.0M | Equity (common) | United States | USD |
| 5 | UnitedHealth Group, Inc. | US91324P1021 | 4.98% | $3.6M | Equity (common) | United States | USD |
| 6 | Merck & Co., Inc. | US58933Y1055 | 4.26% | $3.1M | Equity (common) | United States | USD |
| 7 | Total Return Swap | No identifier reported | -4.13% | -$3.0M | Equity derivatives | United States | USD |
| 8 | Total Return Swap | No identifier reported | -3.97% | -$2.9M | Equity derivatives | United States | USD |
| 9 | Repurchase Agreement | No identifier reported | 2.91% | $2.1M | Repurchase agreements | United States | USD |
| 10 | Thermo Fisher Scientific, Inc. | US8835561023 | 2.68% | $1.9M | Equity (common) | United States | USD |
| 11 | Amgen, Inc. | US0311621009 | 2.62% | $1.9M | Equity (common) | United States | USD |
| 12 | Gilead Sciences, Inc. | US3755581036 | 2.41% | $1.7M | Equity (common) | United States | USD |
| 13 | Intuitive Surgical, Inc. | US46120E6023 | 2.18% | $1.6M | Equity (common) | United States | USD |
| 14 | Pfizer, Inc. | US7170811035 | 2.15% | $1.6M | Equity (common) | United States | USD |
| 15 | Abbott Laboratories | US0028241000 | 2.15% | $1.6M | Equity (common) | United States | USD |
| 16 | Repurchase Agreement | No identifier reported | 1.83% | $1.3M | Repurchase agreements | United States | USD |
| 17 | Bristol-Myers Squibb Co. | US1101221083 | 1.68% | $1.2M | Equity (common) | United States | USD |
| 18 | CVS Health Corp. | US1266501006 | 1.67% | $1.2M | Equity (common) | United States | USD |
| 19 | Danaher Corp. | US2358511028 | 1.66% | $1.2M | Equity (common) | United States | USD |
| 20 | Vertex Pharmaceuticals, Inc. | US92532F1003 | 1.64% | $1.2M | Equity (common) | United States | USD |
| 21 | Stryker Corp. | US8636671013 | 1.52% | $1.1M | Equity (common) | United States | USD |
| 22 | Repurchase Agreement | No identifier reported | 1.37% | $990K | Repurchase agreements | United States | USD |
| 23 | Medtronic plc | IE00BTN1Y115 | 1.37% | $987K | Equity (common) | Ireland | USD |
| 24 | McKesson Corp. | US58155Q1031 | 1.32% | $948K | Equity (common) | United States | USD |
| 25 | Elevance Health, Inc. | US0367521038 | 1.26% | $905K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Warning: Uses derivatives
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 78.01% | |
| Other | 11.81% | |
| Equity derivatives | -9.72% | |
| Repurchase agreements | 7.12% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 85.55% | |
| Ireland | 1.67% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 87.22% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 68.33% | |
| Industrials | 5.96% | |
| Consumer Staples | 1.67% | |
| Technology | 0.38% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.6310
- 12-month yield
- 0.95%
- Frequency
- Quarterly
- Latest ex-date
- 23 Sep 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.6310) ÷ latest price ($66.31) × 100 = 0.95%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (16 payments)
| Ex-date | Amount per unit |
|---|---|
| 23 Sep 2026 | $0.1260 |
| 24 Jun 2026 | $0.1770 |
| 25 Mar 2026 | $0.1440 |
| 24 Dec 2025 | $0.1840 |
| 24 Sep 2025 | $0.2030 |
| 25 Jun 2025 | $0.2190 |
| 26 Mar 2025 | $0.1340 |
| 23 Dec 2024 | $0.1470 |
| 25 Sep 2024 | $0.1285 |
| 26 Jun 2024 | $0.1725 |
| 20 Mar 2024 | $0.0860 |
| 20 Dec 2023 | $0.0840 |
| 22 Dec 2022 | $0.1065 |
| 22 Jun 2022 | $0.0015 |
| 23 Mar 2022 | $0.0455 |
| 23 Dec 2021 | $0.0225 |
Filings and sources
- Form N-PORT report for May 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000014253) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- RXL and TQQQ ProShares UltraPro QQQ
- RXL and SOXL Direxion Daily Semiconductor Bull 3X ETF
- RXL and BBJP JPMorgan BetaBuilders Japan ETF
- RXL and QLD ProShares Ultra QQQ